Skip to main content
main-content

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

BMC Clinical Pathology 1/2017

Primary hyperoxaluria detected by bone marrow biopsy: case report

Zeitschrift:
BMC Clinical Pathology > Ausgabe 1/2017
Autoren:
F. Nachite, M. Dref, A. Fakhri, H. Rais

Abstract

Background

Primary hyperoxaluria is a rare disease with an estimated prevalence of 1 to 3 cases per million. It is due to a hepatic enzyme deficiency responsible for an endogenous overproduction of oxalate. Oxalate crystals commonly deposit in the kidney and more rarely in bone marrow.
The literature has reported, to the best of our knowledge, only two cases of hyperoxaluria diagnosed by bone marrow biopsy and our case is the only one that does not show radiological bone lesions.

Case presentation

A young 22 year old chronic hemodialysis patient with nephrocalcinosis. The patient had a personal and family history of recurrent kidney stones. He presented bone pain with worsening of his general state. On physical examination, no organomegaly was detected. Biological check-up showed only a normochromic and normocytic regenerative anemia resistant to treatment and a bone marrow biopsy was performed. It showed deposits of crystals of oxalate in the bone marrow surrounded by inflammatory reaction against foreign bodies. Given our context, no liver biopsy or genetic studies, which are gold standard of diagnosis testing, were done. The diagnosis of primary hyperoxaluria was made based on morphological characteristics of crystals, his medical and family history, and the absence of any secondary cause of the condition. Since curative treatment is not available in our country, the patient only receives a palliative treatment.

Conclusion

Primary hyperoxaluria is rarely evoked by the histological study of a bone marrow biopsy. The lack of the possibility of the only effective treatment in our context and the diagnosis, usually late, of this pathology are at the origin of the fatal evolution of the disease in almost all the cases.
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2017

BMC Clinical Pathology 1/2017 Zur Ausgabe


 

Neu im Fachgebiet Pathologie

22.05.2019 | Molekular- und Tumorbiologie | CME | Ausgabe 3/2019

Mikrosatelliteninstabilität

Aktueller Überblick über Methoden und Anwendungen

17.05.2019 | Schwerpunkt: Präzisionsonkologie | Ausgabe 3/2019 Open Access

Das nationale Netzwerk Genomische Medizin (nNGM)

Modell für eine innovative Diagnostik und Therapie von Lungenkrebs im Spannungsfeld eines öffentlichen Versorgungsauftrages

15.05.2019 | Schwerpunkt: Endokrine/Neuroendokrine Pathologie | Ausgabe 3/2019

Gering differenzierte Schilddrüsenkarzinome

Eine unterdiagnostizierte Entität

14.05.2019 | Schwerpunkt: Präzisionsonkologie | Ausgabe 3/2019

Digitalisierung und Multiplex-IHC als prädiktive Biomarker für neue Immuntherapeutika

Neue Herausforderungen an die Immunhistochemie
Bildnachweise